Washington, DC - April 6, 2020 — The global COVID-19 pandemic is an unprecedented challenge. Every day, academic and government researchers are working tirelessly to find solutions that can be applied to new equipment and treatments — from clinical trials to face shields — needed to save lives.
In an effort to disseminate information about COVID-19 research being undertaken at academic and federal labs around the globe, AUTM and the Federal Laboratory Consortium are working together to track developments in the fight against the virus. That information is available for AUTM here and FLC here, and is updated daily.
Both organizations are encouraging labs to share their COVID updates on Twitter with the hashtag #COVID19Research and to post their technologies to the AUTM Innovation Marketplace where they are tagged with the keyword COVID and are searchable by the media.
AUTM CEO Dr. Stephen J. Susalka is available for interviews to discuss:
AUTM is the nonprofit leader in efforts to educate, promote and inspire professionals, throughout their careers, to support the development of academic research that changes the world. AUTM’s community is comprised of more than 3,000 members who work in more than 800 universities, research centers, hospitals, businesses and government organizations around the globe. To learn more, visit www.autm.net.
About the FLC
The Federal Laboratory Consortium for Technology Transfer (FLC) is a formally chartered, nationwide network of more than 300 federal laboratories, agencies, and research centers that foster commercialization best practice strategies and opportunities for accelerating federal technologies from out of the labs and into the marketplace. To learn more, visit www.federallabs.org.
Leef Smith Barnes, AUTM Chief Marketing Officer, T: 703-870-4895, email: [email protected]
Carolina Olivieri, FLC Marketing Director, T: 202-390-1962, email: [email protected]